戻る Agenda
Patient Involvement in the Development and Safe Use of Medicines
Session Chair(s)
Lembit Rago, DrMed, MD, PHD
Secretary General
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Patient engagement has dramatically evolved in product development globally during the past decade and a number of different initiatives propose a variety of methodologies to best capture the patient perspective throughout the life cycle of medicines
Speaker(s)
Academic perspective: establishing a conceptual and methodological framework for patient engagement in pharmacovigilance
Patrick Brown, PHD, MA
University of Amsterdam, Netherlands
Associate professor
CSetting up international standards for patient involvement throughout the life cycle of medicines
Lembit Rago, DrMed, MD, PHD
Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Secretary General
Patients’ challenges when supporting medicine’s safety monitoring – how can we improve?
François Houyez
European Organisation for Rare Diseases (EURORDIS), France
Treatment Information and Access Director, Health Policy Advisor
Direct patient reporting: implementing a key milestone in pharmacovigilance
Florence van Hunsel, PHARMD, PHD
Netherlands Pharmacovigilance Centre Lareb, Netherlands
Head Signal Detection